Nasdaq

Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- The clinical effectiveness of Getinge's patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient's own respiratory drive to ...
Nature

The impact of neurally adjusted ventilatory assist mode on respiratory severity score and energy expenditure in infants: a randomized crossover trial

Examine respiratory severity scores (RSS) (mean airway pressure × fraction of inspired oxygen) and resting energy expenditure (REE) on neurally adjusted ventilatory assist (NAVA) compared with ...
Nasdaq

The ventilation technology from Getinge that is groundbreaking both for premature babies and adults

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and ...
Nature

Patient-Ventilator Interaction During Neurally Adjusted Ventilatory Assist in Low Birth Weight Infants

The protocol was approved by the Research Ethics Board of Sunnybrook Health Sciences Centre, Toronto, Canada. Written informed consent was obtained from a parent or guardian. Infants were eligible for ...
Scientific American

A Neonatal Medical Technology is Poised to Transform ICUs

This ventilation technology for premature babies is also groundbreaking for adult intensive care. This series was produced by Getinge for Scientific American Custom Media, a division separate from the ...
National Institute for Health and Care Excellence

Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children

A literature search was carried out for this briefing in accordance with the interim process and methods statement. This briefing includes the most relevant or best available published evidence ...